Simplex Trading’s Genocea Biosciences, Inc. GNCA Stock Holding History

Simplex Trading’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-30	Closed	-$8K	–	11143
2021 Q1	$8K	Sell	30 -78	-72%	-$231	﹤0.01%	8049
2020 Q4	$26K	Buy	108 +4	+4%	+$9	﹤0.01%	6808
2020 Q3	$23K	Buy	104 +97	+1,386%	+$254	﹤0.01%	6291
2020 Q2	$1K	Buy	+7	New	+$16	﹤0.01%	7479
2019 Q4	–	Sell	-5	Closed	-$1K	–	8462
2019 Q3	$1K	Sell	5 -129	-96%	-$440	﹤0.01%	7139
2019 Q2	$52K	Buy	+134	New	+$699	﹤0.01%	4836
2017 Q4	–	Sell	-68	Closed	-$199K	–	7129
2017 Q3	$199K	Buy	68 +62	+1,033%	+$2.35K	0.01%	1196
2017 Q2	$3K	Buy	+6	New	+$289	﹤0.01%	5119
2016 Q4	–	Sell	-2	Closed	-$2K	–	6918
2016 Q3	$2K	Buy	+2	New	+$78	﹤0.01%	5141

Other funds holding GNCA

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Simplex Trading's GNCA Position: Q3 2022 in Review

Simplex Trading sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2022, closing a stake of 500 shares.

Simplex Trading first reported a position in GNCA in Q3 2016 and held it in 12 quarters. The position peaked at $37K in Q4 2020. 1 fund tracked by Wall St. Rank holds GNCA as of Q3 2022.

Simplex Trading reported no remaining Genocea Biosciences, Inc. position as of Q3 2022 after selling out during the quarter.
Simplex Trading sold 500 Genocea Biosciences, Inc. shares in Q3 2022.
Simplex Trading first reported a position in Genocea Biosciences, Inc. in Q3 2016 and held it in 12 quarters.
Simplex Trading's Genocea Biosciences, Inc. position peaked at $37K in Q4 2020.
1 fund tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.